How a Silicon Valley dealmaker charmed Trump and gave Intel a lifeline

Politics was not Lip-Bu Tan's priority - until Donald Trump made it one. That culminated in the most pivotal meetings of ...

FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Film Bans And Censorship: IFFK, Festivally Not Yours

The exclusion of six films from IFFK has triggered an uneasy debate about censorship, where dissent is not banned outright ...

How Intel CEO Lip-Bu Tan turned Trump’s attack into a White House deal

After a Trump attack over China links, Intel CEO Lip-Bu Tan struck a landmark Oval Office deal, securing billions and a US ...
eLife

Nucleosome wrapping energy in CpG islands and the role of epigenetic base modifications

CpG density and epigenetic modification state modulate DNA mechanics, altering its intrinsic compatibility with nucleosome formation.

How Intel's dealmaker CEO charmed US President Donald Trump

Intel CEO Lip-Bu Tan recently found himself under fire from presidential criticism but skillfully transformed the situation ...

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Wearable Devices and Rokid Partner to Bring Neural Gesture Control to AI and AR Glasses

Consumer bundle planned for Q2 2026 pairsMudra Link with Rokid Glasses, with live demos at CES 2026 Yokneam Illit, Israel, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) ...